Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer

Spencer W. Redding, William R. Kirkpatrick, Brent J. Coco, Lee Sadkowski, Annette W. Fothergill, Michael G. Rinaldi, Tony Y. Eng, Thomas F. Patterson

Research output: Contribution to journalArticle

50 Scopus citations

Abstract

Candida glabrata colonization is common in patients receiving radiation treatment for head and neck cancer, but to our knowledge has never been described as the infecting organism with oropharyngeal candidiasis (OPC). This study presents the first three patients described with C. glabrata OPC in this patient population. Patient 1 developed C. glabrata OPC and required fluconazole, 800 mg/day, for clinical resolution. Antifungal susceptibility testing revealed a MIC of fluconazole of >64 μg/ml. Elapsed time from initial culturing to treatment decision was 7 days. Patients 2 and 3 developed C. glabrata OPC. They were patients in a study evaluating OPC infections, and cultures were taken immediately. CHROMagar Candida plates with 0, 8, and 16 μg of fluconazole/ml were employed for these cultures. Lavender colonies, consistent with C. glabrata, grew on the 0- and 8-μg plates but not on the 16-μg plate from patient 2 and grew on all three plates from patient 3. Based on these data, a fluconazole dose of 200 mg/day was chosen for patient 2 and a dose of 400 mg/day was chosen for patient 3, with clinical resolution in both. Elapsed time from initial culturing to treatment decision was 2 days. C. glabrata does cause OPC in head and neck radiation treatment patients, and the use of fluconazole-impregnated chromogenic agar may significantly reduce treatment decision time compared to that with conventional culturing and antifungal susceptibility testing.

Original languageEnglish (US)
Pages (from-to)1879-1881
Number of pages3
JournalJournal of clinical microbiology
Volume40
Issue number5
DOIs
StatePublished - 2002

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer'. Together they form a unique fingerprint.

  • Cite this

    Redding, S. W., Kirkpatrick, W. R., Coco, B. J., Sadkowski, L., Fothergill, A. W., Rinaldi, M. G., Eng, T. Y., & Patterson, T. F. (2002). Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer. Journal of clinical microbiology, 40(5), 1879-1881. https://doi.org/10.1128/JCM.40.5.1879-1881.2002